List of Esteve patents

Patents where

Current Assignee

Name

Esteve

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent RE39888 Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride	Patent RE39888 was granted and assigned to Esteve on October, 2007 by the United States Patent and Trademark Office.		Esteve	United States Patent and Trademark Office	RE39888	October 16, 2007
‌ US Patent 11478488 Co-crystals of tramadol and coxibs		Esteve	Esteve	United States Patent and Trademark Office	11478488	October 25, 2022
‌ US Patent 11649248 Oxadiazaspiro compounds for the treatment of drug abuse and addiction	Patent 11649248 was granted and assigned to Esteve on May, 2023 by the United States Patent and Trademark Office.	Esteve	Esteve	United States Patent and Trademark Office	11649248	May 16, 2023
‌ US Patent 7514429 Benzoxazinone-derived compounds, their preparation and use as medicaments	Patent 7514429 was granted and assigned to Esteve on April, 2009 by the United States Patent and Trademark Office.		Esteve	United States Patent and Trademark Office	7514429	April 7, 2009
‌ US Patent 11401270 Alcoxyamino derivatives for treating pain and pain related conditions		Esteve	Esteve	United States Patent and Trademark Office	11401270	August 2, 2022
‌ US Patent 9073899 Solid forms of dabigatran etexilate mesylate and processes for their preparation	Patent 9073899 was granted and assigned to Esteve on July, 2015 by the United States Patent and Trademark Office.	Esteve	Esteve	United States Patent and Trademark Office	9073899	July 7, 2015
‌ US Patent 10428051 Substituted amide derivatives having multimodal activity against pain	Patent 10428051 was granted and assigned to Esteve on October, 2019 by the United States Patent and Trademark Office.	Esteve	Esteve	United States Patent and Trademark Office	10428051	October 1, 2019
‌ US Patent 9035070 Process for the preparation of 1-aryl-pyrazol-3-one intermediates useful in the synthesis of sigma receptors inhibitors	Patent 9035070 was granted and assigned to Esteve on May, 2015 by the United States Patent and Trademark Office.		Esteve	United States Patent and Trademark Office	9035070	May 19, 2015
‌ US Patent 9056864 Crystalline form of abacavir that is essentially free of solvent	Patent 9056864 was granted and assigned to Esteve on June, 2015 by the United States Patent and Trademark Office.		Esteve	United States Patent and Trademark Office	9056864	June 16, 2015
‌ US Patent 7902370 Solid forms of the magnesium salt of S-omeprazole and processes for their preparation	Patent 7902370 was granted and assigned to Esteve on March, 2011 by the United States Patent and Trademark Office.		Esteve	United States Patent and Trademark Office	7902370	March 8, 2011
‌ US Patent 10927128 Oxadiazaspiro compounds for the treatment of drug abuse and addiction	Patent 10927128 was granted and assigned to Esteve on February, 2021 by the United States Patent and Trademark Office.	Esteve	Esteve	United States Patent and Trademark Office	10927128	February 23, 2021
‌ US Patent 10941138 Quinoline and isoquinoline derivatives for treating pain and pain related conditions	Patent 10941138 was granted and assigned to Esteve on March, 2021 by the United States Patent and Trademark Office.	Esteve	Esteve	United States Patent and Trademark Office	10941138	March 9, 2021
‌ US Patent 10221134 Processes to produce brivaracetam	Patent 10221134 was granted and assigned to Esteve on March, 2019 by the United States Patent and Trademark Office.	Esteve	Esteve	United States Patent and Trademark Office	10221134	March 5, 2019
‌ US Patent 7671208 Acetone solvate of phthaloyl amlodipine	Patent 7671208 was granted and assigned to Esteve on March, 2010 by the United States Patent and Trademark Office.		Esteve	United States Patent and Trademark Office	7671208	March 2, 2010
‌ US Patent 8097723 Process for the preparation of abacavir	Patent 8097723 was granted and assigned to Esteve on January, 2012 by the United States Patent and Trademark Office.		Esteve	United States Patent and Trademark Office	8097723	January 17, 2012
‌ US Patent 10351535 Piperazine derivatives having multimodal activity against pain	Patent 10351535 was granted and assigned to Esteve on July, 2019 by the United States Patent and Trademark Office.	Esteve	Esteve	United States Patent and Trademark Office	10351535	July 16, 2019
‌ US Patent 8183370 Process for the preparation of abacavir	Patent 8183370 was granted and assigned to Esteve on May, 2012 by the United States Patent and Trademark Office.		Esteve	United States Patent and Trademark Office	8183370	May 22, 2012
‌ US Patent 10407428 Spiro-isoquinoline-1,4′-piperidine compounds having multimodal activity against pain	Patent 10407428 was granted and assigned to Esteve on September, 2019 by the United States Patent and Trademark Office.	Esteve	Esteve	United States Patent and Trademark Office	10407428	September 10, 2019
‌ US Patent 10548909 Co-crystals of tramadol and coxibs	Patent 10548909 was granted and assigned to Esteve on February, 2020 by the United States Patent and Trademark Office.		Esteve	United States Patent and Trademark Office	10548909	February 4, 2020
‌ US Patent 8188285 Purification process of Montelukast and its amine salts	Patent 8188285 was granted and assigned to Esteve on May, 2012 by the United States Patent and Trademark Office.		Esteve	United States Patent and Trademark Office	8188285	May 29, 2012
‌ US Patent 8981105 Process of preparing a thrombin specific inhibitor	Patent 8981105 was granted and assigned to Esteve on March, 2015 by the United States Patent and Trademark Office.		Esteve	United States Patent and Trademark Office	8981105	March 17, 2015
‌ US Patent 11236110 Salts of (R)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one	Patent 11236110 was granted and assigned to Esteve on February, 2022 by the United States Patent and Trademark Office.	Esteve	Esteve	United States Patent and Trademark Office	11236110	February 1, 2022
‌ US Patent 10022359 1,9-diazaspiro undecane compounds having multimodal activity against pain	Patent 10022359 was granted and assigned to Esteve on July, 2018 by the United States Patent and Trademark Office.		Esteve	United States Patent and Trademark Office	10022359	July 17, 2018
‌ US Patent 10590140 Tetrahydropyrimidodiazepine and dihydropyridodiazepine compounds for treating pain and pain related conditions	Patent 10590140 was granted and assigned to Esteve on March, 2020 by the United States Patent and Trademark Office.	Esteve	Esteve	United States Patent and Trademark Office	10590140	March 17, 2020
‌ US Patent 10421750 Substituted morpholine derivatives having activity against pain	Patent 10421750 was granted and assigned to Esteve on September, 2019 by the United States Patent and Trademark Office.		Esteve	United States Patent and Trademark Office	10421750	September 24, 2019

Results per page:

41 results

0 selected

41 results

0 selected